A Multiplex PCR/LDR Assay for the simultaneous identification of category a infectious pathogens: Agents of viral hemorrhagic fever and Variola virus

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Das, Sanchita ^a,f   Rundell, Mark S ^a,g   Mirza, Aashiq H ^a,h   Pingle, Maneesh R ^a,i   Shigyo, Kristi ^a,j   Garrison, Aura R ^b   Paragas, Jason ^c   Smith, Scott K ^d   Olson, Victoria A ^d   Larone, Davise H ^a   Spitzer, Eric D ^e   Barany, Francis ^a   Golightly, Linnie M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^e STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^f NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^g Beckman Coulter Inc   (United States)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

ⁱ Coferon Inc ^*  (United States)

^j HARBOR UCLA MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

AMPLICON; ARTICLE; CLINICAL DATA REPOSITORY; CONTROLLED STUDY; COWPOX VIRUS; CRIMEAN CONGO HEMORRHAGIC FEVER VIRUS; DENGUE VIRUS; EBOLAVIRUS; GENE AMPLIFICATION; JAPANESE ENCEPHALITIS VIRUS; LASSA VIRUS; LIGASE DETECTION REACTION ASSAY; LIMIT OF DETECTION; MARBURGVIRUS; MONKEYPOX VIRUS; MULTIPLEX POLYMERASE CHAIN REACTION; MURRAY VALLEY ENCEPHALITIS VIRUS; NONHUMAN; POWASSAN VIRUS; RIFT VALLEY FEVER VIRUS; SMALLPOX; SMALLPOX VIRUS; ST. LOUIS ENCEPHALITIS VIRUS; TICK BORNE ENCEPHALITIS VIRUS; VACCINIA VIRUS; VIRUS DETECTION; VIRUS HEMORRHAGIC FEVER; VIRUS IDENTIFICATION; VIRUS STRAIN; WEST NILE VIRUS; YELLOW FEVER VIRUS; HEMORRHAGIC FEVERS, VIRAL; HUMAN; ISOLATION AND PURIFICATION; PROCEDURES; VIROLOGY; VIRUS;

HEMORRHAGIC FEVERS, VIRAL; HUMANS; MULTIPLEX POLYMERASE CHAIN REACTION; SMALLPOX; VARIOLA VIRUS; VIRUSES;

EID: 84946593030     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138484     Document Type: Article

References (58)

1. Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM, Jahrling PB, et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA. 2002; 287(18):2391-405.
2. Bannister B. Viral haemorrhagic fevers imported into non-endemic countries: risk assessment and management. Br Med Bull. 2010; 95:193-225. doi: 10.1093/bmb/ldq022
3. Mardani M, Keshtkar-Jahromi M, Ataie B, Adibi P. Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran. Am J Trop Med Hyg. 2009; 81(4):675-8. doi: 10.4269/ajtmh. 2009.09-0051
4. Maltezou HC, Andonova L, Andraghetti R, Bouloy M, Ergonul O, Jongejan F, et al. Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness. Euro Surveill. 15(10):19504.
5. Teets FD, Ramgopal MN, Sweeney KD, Graham AS, Michael SF, Isern S. Origin of the dengue virus outbreak in Martin County, Florida, USA 2013. Virology Reports. 2014; 1-2:2-8. doi: 10.1016/j.virep.2014.05.001
6. Imported case of Marburg hemorrhagic fever-Colorado, 2008. MMWR Morb Mortal Wkly Rep. 2009; 58(49):1377-81.
7. Towner JS, Sealy TK, Khristova ML, Albarino CG, Conlan S, Reeder SA, et al. Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog. 2008; 4(11):e1000212. doi: 10.1371/journal.ppat.1000212
8. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, et al. Emergence of Zaire Ebola Virus Disease in Guinea-Preliminary Report. N Engl J Med. 2014. doi: 10.1056/NEJMoa1404505
9. Gear JS, Cassel GA, Gear AJ, Trappler B, Clausen L, Meyers AM, et al. Outbreake of Marburg virus disease in Johannesburg. Br Med J. 1975; 4(5995):489-93.
10. Hartman AL, Towner JS, Nichol ST. Ebola and marburg hemorrhagic fever. Clin Lab Med. 2010; 30 (1):161-77. doi: 10.1016/j.cll.2009.12.001
11. Feldmann H. Ebola-A Growing Threat? N Engl J Med. 2014. doi: 10.1056/NEJMp1405314
12. Green A. Ebola emergency meeting establishes new control centre. Lancet. 2014; 384(9938):118.
13. Fauci AS. Ebola-underscoring the global disparities in health care resources. N Engl J Med. 2014; 371(12):1084-6. doi: 10.1056/NEJMp1409494
14. Bowick GC, Barrett AD. Comparative pathogenesis and systems biology for biodefense virus vaccine development. J Biomed Biotechnol. 2010; 2010:236528. doi: 10.1155/2010/236528
15. He J, Kraft AJ, Fan J, Van Dyke M, Wang L, Bose ME, et al. Simultaneous detection of CDC Category "A" DNA and RNA Bioterrorism agents by use of multiplex PCR & RT-PCR enzyme hybridization assays. Viruses. 2009; 1(3):441-59.
16. Narayanan A, Bailey C, Kashanchi F, Kehn-Hall K. Developments in antivirals against influenza, smallpox and hemorrhagic fever viruses. Expert Opin Investig Drugs. 2011; 20(2):239-54. doi: 10.1517/13543784.2011.547852
17. Damon IK. Genus Orthopoxvirus: Variola virus. In: Mercer AA, Schmidt A, Weber O, editor. Poxviruses. Basel: Birkhauser Verlag; 2007. p. 47-64.
18. McFadden G. Killing a killer: what next for smallpox? PLoS Pathog. 2010; 6(1):e1000727. . doi: 10.1371/journal.ppat.1000727
19. Gire SK, Goba A, Andersen KG, Sealfon RS, Park DJ, Kanneh L, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014; 345(6202):1369-72. doi: 10.1126/science.1259657
20. Cosgrove SE, Perl TM, Song X, Sisson SD. Ability of physicians to diagnose and manage illness due to category A bioterrorism agents. Arch Intern Med. 2005; 165(17):2002-6.
21. Yang S, Rothman RE. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect Dis. 2004; 4(6):337-48.
22. Nisii C, Castilletti C, Di Caro A, Capobianchi MR, Brown D, Lloyd G, et al. The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats. Clin Microbiol Infect. 2009; 15(8):720-6. doi: 10.1111/j.1469-0691.2009.02946.x
23. Olson VA, Laue T, Laker MT, Babkin IV, Drosten C, Shchelkunov SN, et al. Real-Time PCR system fordetection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol. 2004;42(5):1940-6.
24. Palacios G, Briese T, Kapoor V, Jabado O, Liu Z, Venter M, et al. MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever. Emerg Infect Dis. 2006; 12(4):692-5.
25. Sall AA, Macondo EA, Sene OK, Diagne M, Sylla R, Mondo M, et al. Use of reverse transcriptase PCR in early diagnosis of Rift Valley fever. Clin Diagn Lab Immunol. 2002; 9(3):713-5.
26. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 2004; 78(8):4330-41.
27. Trombley AR, Wachter L, Garrison J, Buckley-Beason VA, Jahrling J, Hensley LE, et al. Comprehensive panel of real-Time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg. 2010; 82(5):954-60. Epub 2010/05/05. doi: 10.4269/ajtmh.2010.09-0636
28. FilmArray Biothreat Panel [September 4, 2014]. Available from: http://www.biofiredx.com/media/Infosheet-FilmArray-Biothreat-0237.pdf.
29. Ebola Zaire (EZ1) rRT-PCR (TaqMan) Assay On ABI 7500 Fast Dx, LightCycler, and JBAIDS [September 4, 2014]. Available from: http://www.fda.gov/downloads/medicaldevices/safety/emergencysituations/ucm408334.pdf
30. Hasib L, Dilcher M, Hufert F, Meyer-Konig U, Weidmann M. Development of a flow-Through [corrected] microarray based reverse transcriptase multiplex ligation-dependent probe amplification assay for the detection of European Bunyaviruses. [corrected]. Mol Biotechnol. 2011; 49(2):176-86. Epub 2011/03/11. doi: 10.1007/s12033-011-9389-3
31. Weidmann M, Armbruster K, Hufert FT. Challenges in designing a Taqman-based multiplex assay for the simultaneous detection of Herpes simplex virus types 1 and 2 and Varicella-zoster virus. J Clin Virol. 2008; 42(4):326-34. Epub 2008/04/29. doi: 10.1016/j.jcv.2008.03.005
32. Watt A, Moukambi F, Banadyga L, Groseth A, Callison J, Herwig A, et al. A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity. J Virol. 2014; 88(18):10511-24. doi: 10.1128/JVI.01272-14
33. Goodman JL. Studying "secret serums"-Toward safe, effective Ebola treatments. N Engl J Med. 2014; 371(12):1086-9. doi: 10.1056/NEJMp1409817
34. Busti E, Bordoni R, Castiglioni B, Monciardini P, Sosio M, Donadio S, et al. Bacterial discrimination by means of a universal array approach mediated by LDR (ligase detection reaction). BMC Microbiol. 2002; 2:27.
35. Castiglioni B, Rizzi E, Frosini A, Sivonen K, Rajaniemi P, Rantala A, et al. Development of a universal microarray based on the ligation detection reaction and 16S rrna gene polymorphism to target diversity of cyanobacteria. Appl Environ Microbiol. 2004; 70(12):7161-72. doi: 10.1128/AEM.70.12.7161-7172.2004
36. Pingle M, Rundell M, Das S, Golightly LM, Barany F. PCR/LDR/universal array platforms for the diagnosis of infectious disease. Methods Mol Biol. 2010; 632:141-57. doi: 10.1007/978-1-60761-663-4-9
37. Das S, Pingle MR, Munoz-Jordan J, Rundell MS, Rondini S, Granger K, et al. Detection and serotyping of dengue virus in serum samples by multiplex reverse transcriptase PCR-ligase detection reaction assay. J Clin Microbiol. 2008; 46(10):3276-84. doi: 10.1128/JCM.00163-08
38. Rondini S, Pingle MR, Das S, Tesh R, Rundell MS, Hom J, et al. Development of multiplex PCR-ligase detection reaction assay for detection of West Nile virus. J Clin Microbiol. 2008; 46(7):2269-79. doi: 10.1128/JCM.02335-07
39. Esposito JJ, Sammons SA, Frace AM, Osborne JD, Olsen-Rasmussen M, Zhang M, et al. Genome sequence diversity and clues to the evolution of variola (smallpox) virus. Science. 2006; 313 (5788):807-12.
40. WHO Advisory Committee on Variola Virus Research Report of the Eleventh Meeting, Geneva, Switzerland, 4-5 November 2009, (2009).
41. Pang Z, Li A, Li J, Qu J, He C, Zhang S, et al. Comprehensive multiplex one-step real-Time TaqMan qRT-PCR assays for detection and quantification of hemorrhagic fever viruses. PLoS One. 2014; 9(4): e95635. doi: 10.1371/journal.pone.0095635
42. Briand S, Bertherat E, Cox P, Formenty P, Kieny MP, Myhre JK, et al. The international Ebola emergency. N Engl J Med. 2014; 371(13):1180-3. doi: 10.1056/NEJMp1409858
43. Le Guenno B, Formenty P, Wyers M, Gounon P, Walker F, Boesch C. Isolation and partial characterization of a new strain of Ebola virus. Lancet. 1995; 345(8960):1271-4.
44. Outbreak news. Ebola Reston in pigs and humans, Philippines. Wkly Epidemiol Rec. 2009; 84(7):49-50.
45. Smith DH, Johnson BK, Isaacson M, Swanapoel R, Johnson KM, Killey M, et al. Marburg-virus disease in Kenya. Lancet. 1982; 1(8276):816-20.
46. Burt FJ, Swanepoel R. Molecular epidemiology of African and Asian Crimean-Congo haemorrhagic fever isolates. Epidemiol Infect. 2005; 133(4):659-66.
47. Essbauer S, Meyer H. Genus Orthopoxvirus: Monkeypox virus. In: Mercer AA, Schmidt A. Weber O., editor. Poxviruses. Basel: Birkhauser Verlag; 2007. p. 65-74.
48. Eis-Hubinger AM, Gerritzen A, Schneweis KE, Pfeiff B, Pullmann H, Mayr A, et al. Fatal cowpox-like virus infection transmitted by cat. Lancet. 1990; 336(8719):880.
49. Pelkonen PM, Tarvainen K, Hynninen A, Kallio ER, Henttonen K, Palva A, et al. Cowpox with severe generalized eruption, Finland. Emerg Infect Dis. 2003; 9(11):1458-61.
50. Garrison AR, Alakbarova S, Kulesh DA, Shezmukhamedova D, Khodjaev S, Endy TP, et al. Development of a TaqMan minor groove binding protein assay for the detection and quantification of Crimean-Congo hemorrhagic fever virus. Am J Trop Med Hyg. 2007; 77(3):514-20.
51. Riemann K, Adamzik M, Frauenrath S, Egensperger R, Schmid KW, Brockmeyer NH, et al. Comparison of manual and automated nucleic acid extraction from whole-blood samples. J Clin Lab Anal. 2007; 21(4):244-8.
52. Schuurman T, de Boer R, Patty R, Kooistra-Smid M, van Zwet A. Comparative evaluation of in-house manual, and commercial semi-Automated and automated DNA extraction platforms in the sample preparation of human stool specimens for a Salmonella enterica 5'-nuclease assay. J Microbiol Methods. 2007; 71(3):238-45.
53. Rundell MS, Pingle M, Das S, Hussain A, Ocheretina O, Charles M, et al. A multiplex PCR/LDR assay for simultaneous detection and identification of the NIAID category B bacterial food and water-borne pathogens. Diagn Microbiol Infect Dis. 2014; 79(2):135-40. doi: 10.1016/j.diagmicrobio.2014.02.022
54. Barany F. Genetic disease detection and DNA amplification using cloned thermostable ligase. Proc Natl Acad Sci U S A. 1991; 88(1):189-93.
55. Barany F. The ligase chain reaction in a PCR world. PCR Methods Appl. 1991; 1(1):5-16.
56. Favis R, Day JP, Gerry NP, Phelan C, Narod S, Barany F. Universal DNA array detection of small insertionsand deletions in BRCA1 and BRCA2. Nat Biotechnol. 2000; 18(5):561-4. doi: 10.1038/75452
57. Gerry NP, Witowski NE, Day J, Hammer RP, Barany G, Barany F. Universal DNA microarray method for multiplex detection of low abundance point mutations. J Mol Biol. 1999; 292(2):251-62. doi: 10.1006/jmbi.1999.3063
58. Pingle MR, Granger K, Feinberg P, Shatsky R, Sterling B, Rundell M, et al. Multiplexed identification of blood-borne bacterial pathogens by use of a novel 16S rRNA gene PCR-ligase detection reaction-capillary electrophoresis assay. J Clin Microbiol. 2007; 45(6):1927-35.